Baltimore Capital Management Inc. Buys Shares of 4,780 iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Baltimore Capital Management Inc. bought a new position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the 1st quarter, Holdings Channel reports. The fund bought 4,780 shares of the financial services provider’s stock, valued at approximately $534,000.

A number of other hedge funds have also bought and sold shares of IBB. Ellis Investment Partners LLC boosted its holdings in shares of iShares Nasdaq Biotechnology ETF by 10,590.0% during the 1st quarter. Ellis Investment Partners LLC now owns 1,761,815 shares of the financial services provider’s stock worth $1,761,000 after buying an additional 1,745,334 shares during the period. Deutsche Bank AG boosted its holdings in shares of iShares Nasdaq Biotechnology ETF by 32,925.6% during the 4th quarter. Deutsche Bank AG now owns 1,683,314 shares of the financial services provider’s stock worth $162,320,000 after buying an additional 1,678,217 shares during the period. State of Tennessee Treasury Department bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter worth $40,732,000. Joseph P. Lucia & Associates LLC bought a new stake in shares of iShares Nasdaq Biotechnology ETF during the 1st quarter worth $2,049,000. Finally, Tibra Equities Europe Ltd boosted its holdings in shares of iShares Nasdaq Biotechnology ETF by 240.4% during the 4th quarter. Tibra Equities Europe Ltd now owns 166,769 shares of the financial services provider’s stock worth $16,082,000 after buying an additional 117,781 shares during the period. 73.90% of the stock is owned by institutional investors.

NASDAQ IBB opened at $103.41 on Thursday. iShares Nasdaq Biotechnology ETF has a 1 year low of $89.01 and a 1 year high of $122.97.

ILLEGAL ACTIVITY WARNING: This story was first published by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright laws. The original version of this story can be read at https://sportsperspectives.com/2019/06/13/baltimore-capital-management-inc-buys-shares-of-4780-ishares-nasdaq-biotechnology-etf-nasdaqibb.html.

About iShares Nasdaq Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also: What does a hold rating mean?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.